The association between dietary glycemic and insulin indices with incidence of cardiovascular disease: Tehran lipid and glucose study by Teymoori, F. et al.
RESEARCH ARTICLE Open Access
The association between dietary glycemic
and insulin indices with incidence of
cardiovascular disease: Tehran lipid and
glucose study
Farshad Teymoori1,2, Hossein Farhadnejad1, Parvin Mirmiran1*, Milad Nazarzadeh3 and Fereidoun Azizi4
Abstract
Background: The present study was conducted to investigate the association of dietary insulin index(II), insulin
load(IL), glycemic index(GI), and glycemic load(GL) with the risk of cardiovascular disease(CVD).
Methods: This cohort study was conducted within the framework of the Tehran Lipid and Glucose Study on 2198
subjects, aged≥19 years old, who were followed-up for a median (IQR) 6.7 (6.1–7.1) years. Dietary GI, GL, II, and IL
were calculated using a food frequency questionnaire at the baseline. Multivariate Cox proportional hazard
regression models were used to estimate the risk of CVD across quartiles of dietary insulin and glycemic indices.
Results: Mean ± SD age of the subjects(44.9% men) was 38.3 ± 13.4 years. During a mean of 2406 ± 417 person-
years of follow-up, 76(3.5%) new cases of the CVD were ascertained. The mean ± SD of II, IL, GI, and GL of
participants were 51.7 ± 6.5, 235.8 ± 90.2, 61.9 ± 7.8, and 202.2 ± 78.1, respectively. After adjusting for the variables of
age, sex, smoking, physical activity, daily energy intake, body mass index, diabetes, and hypertension, the hazard
ratio (HR) of the highest quartile of dietary GL was 2.77(95%CI:1.00–7.69,P for trend:0.033) compared to the lowest
one. Also, each one SD increase in the GL score was associated with a higher risk of CVD[(RR:1.46;CI:1.00–2.16),P-
value = 0.047]. However, there was no significant association between the dietary GI, II, and IL and risk for CVD
incidence.
Conclusions: Our results suggested that a high GL diet can increase the incidence of CVD, whereas high dietary II
and IL were not associated with the risk of CVD among adults.
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Background
Cardiovascular disease (CVD), as the main global health
problem causes a greater rate of comorbidities and mor-
tality worldwide [1]. The obesity, elevated blood pres-
sure, dyslipidemia, hyperglycemia, and insulin resistance
(IR) are the main risk factors of CVD [2, 3], all of which
are influenced by the dietary intakes. Several studies
have shown the associations between the low fiber diet
and overweight and IR, high sodium intake and hyper-
tension, high saturated fatty acids and hypercholesterol-
emia and atherosclerosis, as well as a diet rich in the
refined grain and simple sugar and hyperglycemia and
IR [4–6].
Glycemic index (GI) and glycemic load (GL) are com-
monly used for the estimation of the insulinogenic ef-
fects of the foods and indicate the rate of the increase in
the blood sugar after consumption of the carbohydrate-
containing foods [ 7]. However, the serum response of
glucose is not necessarily in accordance with the insulin
response. Although, the insulin response is almost in-
duced by the carbohydrates, other nutrients such as diet-
ary protein and fats can influence the insulin secretion
[8]. So, based on the concept of insulinogenic effects of
the foods on the development of the chronic disease, re-
cently, insulin indices (IIs) of the foods including dietary
insulin index (II) and insulin load (IL) have been intro-
duced, which can predict the overall insulin load of the
main part of the diet; consequently estimating the odds
for the occurrence of hyperinsulinemia [8, 9]. As the IIs
compute based on the calorie content of the foods, ra-
ther than the glycemic indices, determined based on the
carbohydrate content of the foods, they also provide the
ability for assessing the insulin response induced by low
or free-carbohydrate foods.
Previous reports indicate a direct association between
the GI, and GL and the CVD risk factors such as high
low-density lipoprotein -cholesterol and diabetes; how-
ever, findings about the incidence of CVD are not defin-
ite, and they seem to be a risk factor of CVD among the
women, not for men [10, 11]. There are limited studies
on the relation of the insulin indices with CVD risk fac-
tors, which indicating controversial findings [12–15].
Nimptsch et al. demonstrated that the II was related to
higher triglycerides and lower high-density lipoprotein
cholesterol (HDL-C) and showed no association with BS
and C-reactive protein (CRP) [15]. In another study, IL
indicated no association with triglycerides, HDL-C, and
obesity; however, it had a positive association with fast-
ing blood glucose and CRP [14]. Also, IIs are associated
with greater odds of obesity and IR [12, 13].
Regarding the well-known association between hyper-
insulinemia with the risk of CVD [16], and also the pre-
dictive potential of the IIs for determining the insulin
response, assessing the relationship between the IIs and
development of CVD may give us more practical infor-
mation about the diet therapy for preventing the risk of
CVD. To the best of our knowledge, there is no previous
study assessed the relationship between the IIs and the
risk of CVD incidence, therefore this study was designed
to investigate the association of the dietary II, IL, GI,




The present study was fulfilled within the framework of
the Tehran Lipid and Glucose Study (TLGS). The TLGS
has been performed to assess the risk factors of chronic
diseases among Tehranian population, (capital of Iran),
which included 15,005 participants aged≥3 years old.
This ongoing population-based cohort study initiated in
1999 (baseline phase) and its data are being collected
prospectively at 3-year intervals; details of the TLGS
have been expressed previously [17]. In the third phase
of the TLGS (2006–08), among 12,523 participants,
3652 individuals were randomly considered for nutri-
tional assessment. After excluding the subjects aged< 19
years (n = 550) and those with incomplete information
(n = 187) at the baseline, among 2915 participants aged
19 to 84 years, individuals with a history of myocardial
infarction, stroke, and cancer (n = 40), those who re-
ported a daily energy intake outside the range of 800–
4200 kcal/ day (n = 163) or had specific diets (n = 376),
and pregnant and lactating women (n = 52) were ex-
cluded from the study; some individuals fell into more
than a exclusion category. Finally, 2362 participants were
followed-up until March 2015 (Survey 5 of the TLGS:
2012–2015), with a mean period of 6.7 years from the
baseline examination. After excluding the participants
who were missed to follow up (n = 164), final analyses
were conducted on 2198 adult subjects (Fig. 1).
Data collection and measurments
Materials and Methods of the TLGS has been described
in detail previously [17, 18]. A standard questionnaire
was used to determine the information of participants
on various socio-demographic variables including sex,
age, smoking status, medical history, and drug history.
Also, The antropometrics measurments including weight
and height, and also blood pressure level of individuals
were determined using standard protocols as previously
reported [17, 18]. The formula for calculation of body
mass index (BMI) is weight in kg divided by height in
m2. The physical activity level of participants was
assessed using Modifiable Activity Questionnaire. The
validation of this questionnaire has previously been done
for the Iranian population [19]. Furthermore, we took a
blood sample at the TLGS research laboratory after 12–
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14 h of overnight fasting based on the standard protocol
to measure fasting blood glucose (FBG) [17, 18].
We used a valid and reliable 168-semi-quantitative
food frequency questionnaire (FFQ) to determine the
dietary data of patrticipants at the baseline (third phase
of the TLGS) [20]. Food intakes of the study population
over the previous year on a daily, weekly or monthly
basis were assessed by trained and experienced nutrition
experts. Using the United States Department of Agricul-
ture (USDA) food composition table (FCT), energy and
nutrients content was computed. Local food items that
were not available in USDA FCT, was analyzed using
The Iranian FCT.
For each carbohydrate-containing food, glycemic index
(GI) is defined as the area under the blood glucose re-
sponse curve over 2 h after eating the food relative to
that after consuming the equivalent amount of carbohy-
drate as glucose or white bread. The GI value of each
food item was obtained from the international table of
GI and from the publication that lists the GI of Iranian
foods [21, 22]. Dietary GI is calculated by multiplying
the carbohydrate content of each food item by the num-
ber of servings/d and by the GI and then dividing by
total daily carbohydrate intake. Dietary GL is also calcu-
lated by multiplying the carbohydrate content of each
food item by the number of servings/d and by the GI.
We used the published data of three previous studies
by Jennie C Brand-Miller at the University of Sydney to
measure the insulin indices including II and IL [8, 9, 23].
In the calculation of insulin index (II), postprandial
plasma insulin response after consumption of each food
compares with a reference food including glucose or
white bread. The insulin index value was computed by
dividing the area under the insulin response curve for
1000 kJ (239 kcal) of each food by the area under the in-
sulin response curve for 1000 kJ (239 kJ) of the reference
food 8. We matched the food items of our FFQ with pre-
vious food items in which their II was calculated previ-
ously by Jennie C Brand-Miller et al. Then, the total
dietary insulin load (IL) of the whole diet during the past
year for each of the study population by multiplying the
insulin index value of each food by the total energy in-
take contributed by that food and summing values for
all food items reported [24]. The dietary II of the whole
diet was calculated by dividing the dietary IL by the total
energy intake [24].
Definitions
The detailed information on CVD outcomes ascertain-
ment has been documented previously [25, 26], in which
CVD was defined as any coronary heart disease (CHD)
events, CVD death (fatal CHD, fatal myocardial
Fig. 1 Flow chart of the Tehran Lipid and Glucose Study (TLGS) participants
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infarction (MI), and fatal stroke), or stroke [27]. Coron-
ary heart disease events considered cases of definite MI
(diagnostic ECG and biomarkers), probable MI (positive
ECG findings, cardiac symptoms or signs, and missing
biomarkers or positive ECG findings and equivocal bio-
markers), and angiographic confirmed CHD. Stroke in
individuals was defined as a new neurological deficit that
lasted at least on day. Previous ischemic heart disease
and/or cerebrovascular accidents was considered as his-
tory of CVD.
We used JNC8 criteria for determining hypertension
as systolic blood pressure ≥ 140, or diastolic blood pres-
sure ≥ 90, or using antihypertensive drugs in subjects,
aged < 60 years and systolic blood pressure ≥ 150, or dia-
stolic blood pressure ≥ 90 or taking antihypertensive
medications in subjects, aged > 60 years [28].
Type 2 diabetes was described as a fasting blood glu-
cose of 126 mg/dl and higher, 2-h blood glucose of 200
mg/dl and higher, or being on anti-diabetic medication
[29].
Statistical analysis
All statistical analyses were performed using the Statis-
tical Package for Social Sciences (Version 15.0; SPSS,
Chicago, IL). The histogram charts and Kolmogorov–
Smirnov test were used to assess the normality of the
variables. Inviduals were categorized based on quartiles
of II, IL, GI, and GL. Presentation of the baseline charac-
teristics among subjects was reported according to quar-
tiles of IL and GL; as the mean ± SD or median
(interquartile) and percentages for continuous and cat-
egorical variables, respectively. To test the trend of
qualitative and quantitative variables across quartiles of
IL and GL (as the median value in each quartile), Chi-
square and linear regression were used, respectively.
Time to event was determined as time to end of
follow-up (censored cases) or time to having an event,
whichever occurred first. Participants were censored at
the time of death because of non-CVD causes, at the
time of leaving the district or study follow-up end time
of March 2014. We used the Cox proportional hazard
models to estimate multivariate-adjusted hazard ratio
(HR) and 95% confidence interval (CI) for the CVD inci-
dent across quartile of II, IL, GI, and GL and also based
on the continues level of these indices (per 1 SD incre-
ment). We also adjusted the potential confounders in-
cluding age, sex, BMI, physical activity, smoking,
diabetes, and hypertension, and daily energy intake in
Cox regression models. The linear trend of CVD risk in
quartiles of insulinemic and glycemic scores was tested
by entering the median values of each category as a con-
tinuous variable in the different models. The propor-
tional hazards assumption was checked using a log-log
plot, and the assumption was satisfied (lines in the plots
were parallel). P-values < 0.05 were considered to be sta-
tistically significant.
Results
The mean ± SD age and BMI of the participants at base-
line (44.9% men) were 38.3 ± 13.4 (19–84) years and
26.6 ± 4.8 Kg/m2, respectively. The follow up of partici-
pants was started in 2006–2008 and was continued until
the end of 2015 (fifth phase: 2012–2015). During the
median (IQR) 6.7 (6.1–7.1) year of follow-up, 76 (3.5%)
new cases of CVD were ascertained (19–30 years:0 cases,
31–40 years: 1 case, 41–50 years: 17 cases, 51–60 years:
25 cases, 61–70 years: 25 cases, and > 70 years: 8 cases).
The mean ± SD of II, IL, GI, and GL of participants were
51.7 ± 6.5, 235.8 ± 90.2, 61.9 ± 7.8, and 202.2 ± 78.1,
respectively.
Individuals in the highest quartile of IL score were
more likely to be male, physically active, smokers, having
hypertension, and had higher dietary intakes of energy,
refined grain, carbohydrate, and fiber compared to those
with the lowest score. However, participants with higher
IL scores had lower age and lower intakes of fruit and
vegetable, red and processed meat, nuts and legumes,
fat, and protein compared to those with the lowest score.
No significant trends were observed in other baseline
characteristics across quartiles of IL (Table 1).
Individuals in the highest quartile of GL were more
likely to be male, smoker, and being more physically ac-
tive, and had higher dietary intakes of energy, refined
grain, carbohydrate, and fiber. However, age, intakes of
fruit and vegetable, red and processed meat, fat, and pro-
tein were all decreased across the quartiles of GL. No
significant trend was found across quartiles of GL for
BMI, hypertension, diabetes and pre-diabetes, and diet-
ary intakes of nuts and legumes (Table 2).
The association of II, IL, GI, and GL with the inci-
dence of CVD are presented in Table 3. No significant
association was found between the II, IL, GI, and GL
and the risk of CVD incidence after 6.5 years of follow-
up based on the age and sex-adjusted model. However,
in the model fully adjusted for potential confounders in-
cluding age, sex, BMI, physical activity, smoking, dia-
betes, and hypertension, and daily energy intake, the HR
of incidence of CVD in participants who were in the
highest quartile of GL was 2.67 (95% CI: (1.00–7.69), P
for trend = 0.033) compared to those in the lowest one.
In the final adjusted model, other indices showed no sig-
nificant association with the medium to large effect sizes
for increasing the risk of CVD incidence; the HR(95%
CI) of CVD incidence were 1.24 (0.65–2.33), 2.08 (0.70–
6.19), and 1.55 (0.80–2.99) for II, IL, and GI, respectively
in the highest compared to the lowest quartile.
Table 4 shows the association between each SD in-
creasing the insulin and glycemic scores and the risk of
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Table 1 Baseline characteristics of the study population by quartiles of dietary insulin load (N = 2198)
Characteristics Insulin Load P for
trendQ1(n = 549) Q2(n = 550) Q3(n = 549) Q4(n = 550)
Insulin load 137 ± 26 196 ± 14 250 ± 17 359 ± 67 < 0.001
Insulin index 48.6 ± 6.4 50.6 ± 6.2 52.6 ± 5.7 55.0 ± 5.9 < 0.001
Age (years) 39.2 ± 13.4 38.3 ± 13.2 38.7 ± 13.2 37.1 ± 13.5 < 0.05
Male (%) 27.1 36.9 52.8 62.5 < 0.001
Body mass index (kg/m2) 26.8 ± 4.8 26.6 ± 4.6 26.6 ± 4.9 26.3 ± 4.9 NS
Physical activity (MET_h/week) 23.6 (9.3–46.1) 23.4 (10.4–47.8) 24.3(10.4–50.7) 24.8 (10.9–55.5) < 0.001
Current smoker (%) 9.8 10.9 13.3 14.2 < 0.05
Diabetes and pre-diabetes (%) 12.0 10.5 12.9 8.7 NS
Hypertension (%) 8.1 7.7 9.5 12.6 < 0.01
Dietary intakes
Energy (kcal) 1521 ± 396 2019 ± 371 2430 ± 434 3095 ± 529 < 0.001
Fruit and vegetable (serving/d/1000 Kcal) 3.0 ± 1.6 2.8 ± 1.4 2.6 ± 1.3 2.1 ± 1.1 < 0.001
Refined grain (serving/d/1000 Kcal) 2.0 ± 1.1 2.1 ± 1.0 2.3 ± 1.1 2.8 ± 15 < 0.001
Red and processed meat (serving/wk./1000 Kcal) 2.2 (1.3–3.8) 2.3 (1.3–3.7) 2.1 (1.3–3.4) 2.0 (1.1–3.4) < 0.05
Nut and legume (serving/wk./1000 Kcal) 0.99 (0.59–1.69) 0.96 (0.57–1.60) 0.97 (0.58–1.65) 0.87 (0.48–1.46) < 0.05
Carbohydrate (% of energy) 54.9 ± 7.4 56.3 ± 6.8 57.9 ± 6.3 60.1 ± 6.7 < 0.001
Fat (% of energy) 33.9 ± 7.4 32.5 ± 6.6 31.1 ± 6.2 28.7 ± 6.3 < 0.001
Protein (% of energy) 13.8 ± 2.6 13.8 ± 2.3 13.4 ± 2.1 13.3 ± 2.2 < 0.001
Fiber (g/1000 Kcal) 14.9 ± 5.6 15.6 ± 5.5 16.6 ± 6.9 18.1 ± 8.2 < 0.001
Data are presented as the mean ± SD or as the median (25–75 IQR) for continuous variables and as percentages for categorical variables
Table 2 Baseline characteristics of the study population by quartiles of dietary glycemic load (N = 2198)
Characteristics Glycemic load P for
trendQ1(n = 549) Q2(n = 550) Q3(n = 550) Q4(n = 549)
Glycemic load 117 ± 22 167 ± 12 214 ± 16 309 ± 59 < 0.001
Glycemic index 58.4 ± 7.8 60.8 ± 7.0 62.3 ± 6.8 66.2 ± 7.5 < 0.001
Age (years) 39.2 ± 13.8 38.9 ± 13.1 38.0 ± 13.0 37.1 ± 13.6 < 0.01
Male (%) 28.1 39.8 48.5 63.0 < 0.001
Body mass index (kg/m2) 26.9 ± 4.9 26.6 ± 4.6 26.5 ± 5.0 26.3 ± 4.7 NS
Physical activity (MET_h/week) 23.6 (8.9–45.3) 23.8 (9.1–47.1) 24.5 (11.4–52.1) 24.3 (11.3–55.1) < 0.01
Current smoker (%) 9.7 10.2 14.5 13.8 < 0.05
Diabetes and pre-diabetes (%) 13.3 10.9 10.4 9.7 NS
Hypertension (%) 9.5 7.3 10.2 10.8 NS
Dietary intakes
Energy (kcal) 1522 ± 386 2012 ± 373 2430 ± 431 3103 ± 524 < 0.001
Fruit and vegetable (serving/d/1000 Kcal) 2.8 ± 1.5 2.7 ± 1.3 2.7 ± 1.4 2.3 ± 1.3 < 0.001
Refined grain (serving/d/1000 Kcal) 1.9 ± 1.0 2.1 ± 1.0 2.3 ± 1.1 3.0 ± 1.5 < 0.001
Red and processed meat (serving/wk./1000 Kcal) 2.3 (1.2–3.8) 2.2 (1.3–3.5) 2.2 (1.4–3.7) 2.0 (1.1–3.4) < 0.05
Nut and legume (serving/wk./1000 Kcal) 0.97 (0.57–1.63) 0.97 (0.59–1.64) 0.92 (0.53–1.57) 0.95 (0.50–1.57) NS
Carbohydrate (% of energy) 54.1 ± 7.4 56.3 ± 6.5 58.1 ± 6.5 60.7 ± 6.2 < 0.001
Fat (% of energy) 34.3 ± 7.5 32.4 ± 6.4 30.9 ± 6.3 28.5 ± 6.1 < 0.001
Protein (% of energy) 14.1 ± 2.7 13.8 ± 2.3 13.5 ± 2.2 12.9 ± 1.9 < 0.001
Fiber (g/1000 Kcal) 14.9 ± 5.7 15.8 ± 5.7 16.5 ± 6.6 18.0 ± 8.2 < 0.001
Data are presented as the mean ± SD or as the median (IQR) for continuous variables and as percentages for categorical variables
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CVD incident among all participants. In the crude
model, per one SD increasing the II score, the HR (95%
CI) of CVD was 1.29 (1.02–1.62), P-value = 0.029. In the
final model, after adjusting for potential confounders,
each SD increase in the GL score was associated with a
higher risk of CVD [(RR:1.46; CI:1.00–2.16), P-value =
0.047]. However higher score of II, IL, and GI showed
no significant association with the incidence of CVD.
In a subsample of the participants with dysglycemia
(n = 243), it was observed that those in the highest
quartile of II, IL, GI, and GL had a higher risk of CVD
with HR(95% CI) of (1.20 (0.43–3.32), P for trend =
0.610), (5.59 (0.96–32.55), P for trend = 0.046), (3.24
(0.96–11.00), P for trend = 0.097), and (5.66 (1.08–
29.61), P for trend = 0.029), respectively compared to
those in the lowest quartile.
Discussion
The current study showed that the highest score of diet-
ary GL was significantly associated with an increased
Table 3 Relative risk (95% CI) of cardiovascular disease in participants across quartiles of dietary insulin and glycemic scores*
Quartiles P for
trendQ1 Q2 Q3 Q4
Insulin Index
Median (IQR) score 44.3 (41.4–46.3) 50.0 (49.0–50.9) 53.8 (52.8–55.0) 58.9 (57.3–61.5)
CVD/Total 15/549 17/550 15/549 29/550
person-years 3660.2 3605.2 3623.0 3578.8
Incidence rate (10.000 person year) 40.9 (24.6–67.8) 47.0 (29.2–75.7) 41.3 (24.9–68.5) 80.9 (56.2–116.4)
Crude model 1.00 (ref) 1.15 (0.57–2.31) 1.01 (0.49–2.07) 1.98 (1.06–3.69) 0.033
Model 1 1.00 (ref) 1.01 (0.50–2.04) 0.66 (0.32–1.35) 1.10 (0.58–2.08) 0.840
Model 2 1.00 (ref) 1.16 (0.57–2.36) 0.69 (0.33–1.45) 1.24 (0.65–2.33) 0.638
Insulin Load
Median (IQR) score 142.6 (118.8–159.0) 196.0 (183.2–209.4) 248.5 (235.2–264.8) 340.6 (307.4–393.3)
CVD/Total 15/549 18/550 22/549 21/550
person-years 3643.2 3643.5 3630.9 3550.1
Incidence rate (10.000 person year) 41.1 (24.7–68.1) 49.3 (31.0–78.2) 60.4 (39.8–91.8) 59.0 (38.5–90.5)
Crude model 1.00 (ref) 1.19 (0.60–2.37) 1.47 (0.76–2.83) 1.41 (0.73–2.75) 0.279
Model 1 1.00 (ref) 1.26 (0.63–2.50) 1.20 (0.61–2.35) 1.38 (0.71–2.71) 0.386
Model 2 1.00 (ref) 1.52 (0.71–3.27) 1.69 (0.71–3.77) 2.08 (0.70–6.19) 0.238
Glycemic Index
Median (IQR) score 53.0 (49.6–55.1) 59.9 (58.7–61.0) 64.4 (63.3–65.6) 70.6 (68.6–73.3)
CVD/Total 18/550 24/549 15/549 19/550
person-years 3587.6 3603.9 3644.7 3629.6
Incidence rate (10.000 person year) 50.0 (31.5–79.5) 66.4 (44.5–99.2) 41.0 (24.7–68.1) 52.2 (33.3–81.9)
Crude model 1.00 (ref) 1.34 (0.72–2.47) 0.82 (0.41–1.64) 1.05 (0.55–2.00) 0.826
Model 1 1.00 (ref) 1.30 (0.70–2.41) 0.87 (0.43–1.73) 1.27 (0.66–2.43) 0.703
Model 2 1.00 (ref) 1.32 (0.71–2.46) 0.97 (0.48–1.97) 1.55 (0.80–2.99) 0.305
Glycemic Load
Median (IQR) score 120.6 (104.2–134.8) 167.5 (157.5–178.5) 213.5 (200.9–227.4) 292.1 (265.3–333.1)
CVD/Total 18/549 16/550 17/550 25/549
person-years 3606.5 3677.1 3613.3 3570.9
Incidence rate (10.000 person year) 49.8 (31.3–79.0) 43.4 (26.6–70.9) 46.9 (29.2–75.5) 69.9 (47.2–103.4)
Crude model 1.00 (ref) 0.87 (0.44–1.71) 0.94 (0.48–1.83) 1.39 (0.76–2.56) 0.192
Model 1 1.00 (ref) 0.88 (0.44–1.73) 0.97 (0.50–1.91) 1.42 (0.76–2.65) 0.170
Model 2 1.00 (ref) 1.15 (0.54–2.44) 1.53 (0.66–3.50) 2.77 (1.00–7.69) 0.033
*Cox proportional hazard regression models were used to estimate relative risks (RR) and 95% confidence interval (CI)
Model 1: Adjusted for age and sex
Model 2: Additionally adjusted for body mass index, physical activity, smoking (yes or no), daily energy intake, diabetes, and hypertension
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risk of CVD, independently of potential confounding
factors including age, sex, BMI, physical activity, smok-
ing, diabetes, hypertension, and daily energy intake in
the Tehranian adults. However, there was no significant
association between the dietary GI, II, and IL score and
the risk of CVD in the adults.
In the last decade, meta-analyses and review reports
have summarized the findings on the association of GI
and GI with the risk of CVD events [10, 11, 30]; our find-
ings are comparable with the results of these previously
published studies conducted on the adult population
reporting that high dietary GL and GI are associated with
the increased risk of CVD events, specifically for women.
Three review studies have suggested that gender may sig-
nificantly modify the association of dietary GL and GI
with the risk of CVD outcomes [10, 11, 30]. Xiang-yu
et al. revealed that high dietary GL and GI are related to a
23and 13% increase in the risk of CVD events, respect-
ively. This estimated risk of GL and GI was lower for men
than women. This dose-response meta-analysis has found
an increased risk of CVD events by 18% per 50 unit incre-
ment of GL in the diet [10]. Also, based on the findings of
two previously published review studies, a diet with high
GL and GI significantly increased the risk of CVD events
in women but not men [11, 30]. Knopp et al. reported that
the increase in the triacylglycerol and the decrease in the
high-density lipoprotein cholesterol concentration in re-
sponse to a high glycemic diet are greater in the women
than the men, which led to the differences in the results of
the men and women [31].
Iranians consume more than 55% of energy from the
carbohydrate, which is higher than the amounts con-
sumed in most western countries [32]. Our population
has high carbohydrate intakes from plant sources, such as
refined grain, rice, and potato [33, 34]. Therefore, in our
study, white rice and bread especially white bread were
the major contributors to dietary GL and GI; as these food
items have a high content of carbohydrates and a low
amount of fiber, possibly contributing to the development
of cardio-metabolic risk factors. However, higher adher-
ence to the low GL diet characterized by high consump-
tion of whole-grain bread, fruits, vegetables, and legumes
with high fiber content, if combined with lower consump-
tion of white bread and rice could have a protective role
in decreasing the CVD risk [35, 36].
Although the insulin response is almost induced by
the carbohydrates, other nutrients, such as dietary pro-
tein and fats can affect insulin secretion. Protein-rich
foods or some fats can induce the insulin response; also
dietary protein augments the insulin response after con-
suming carbohydrate-containing foods [8]. Recently, pre-
vious studies have reported that the dietary II and IL can
be more applicable to assess the effect of insulin expos-
ure on the development of the non-communicable
chronic diseases than other factors, such as GI, GL, or
total carbohydrate intake; because II is directly based on
the insulin response and this index could directly quan-
tify the insulin secretion in response to the carbohydrate
and protein-rich foods [37]. Despite the lack of longitu-
dinal study on the association of the dietary II and IL
with CVD risk, there are several studies reported the
controversial findings on the association of dietary II or
IL with cardiovascular risk factors, including hypergly-
cemia, insulin resistance, obesity, high level of CRP, and
dyslipidemia [12–15]. Nimptsch et al. showed that diet-
ary II is directly associated with the low HDL-C and
high triglycerides levels in obese individuals; however,
there are no association between the dietary II and IL
and low-density lipoprotein-cholesterol, CRP, and bio-
markers of glycemic control [15]. In a cohort study con-
ducted within the framework of TLGS, dietary II and IL
were mentioned as the independent dietary risk factors
for the risk of insulin resistance [13]. Also, a cross-
sectional study has reported that the high II diet is asso-
ciated with higher odds of obesity among the women,
but not men [12]. Furthermore, Mozaffari et al. indicated
Table 4 Relative risk (95% CI) of cardiovascular disease in
participants per one SD increase in the dietary insulin and
glycemic scores*
Indices Relative Risk (95% CI) P-value
Insulin Index
One SD of score 6.56
Crude model 1.29 (1.02–1.62) 0.029
Model 1 1.00 (0.80–1.26) 0.998
Model 2 1.03 (0.82–1.30) 0.739
Insulin Load
One SD of score 90.20
Crude model 1.10 (0.88–1.36) 0.393
Model 1 1.07 (0.85–1.35) 0.546
Model 2 1.11 (0.74–1.65) 0.597
Glycemic Index
One SD of score 7.84
Crude model 1.02 (0.81–1.28) 0.819
Model 1 1.09 (0.86–1.37) 0.424
Model 2 1.16 (0.92–1.47) 0.185
Glycemic Load
One SD of score 78.18
Crude model 1.11 (0.90–1.38) 0.279
Model 1 1.15 (0.92–1.43) 0.186
Model 2 1.46 (1.00–2.16) 0.047
*Cox proportional hazard regression models were used to estimate relative
risks (RR) and 95% confidence interval (CI)
Model 1: Adjusted for age and sex
Model 2: Additionally adjusted for body mass index, physical activity, smoking
(yes or no), daily energy intake, diabetes, and hypertension
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that the adherence to a high IL diet is positively related
to the serum fasting blood glucose and hs-CRP levels.
However, no association was reported between the high
dietary IL and BMI or lipid profiles [14].
This study is the first study assessed the association of
dietary II and IL with the incidence of CVD events and
our results showed no significant association between
scores of insulin indices and the risk of CVD. Our failure
to find a significant association between dietary II and IL
and the risk of CVD may be due to some reasons. First,
due to the lack of dietary insulin data, some food items
of FFQ, such as some fruits or vegetables were not in-
cluded in the final dietary II and IL scoring, which could
be effective on this association. Second, in the current
study, individuals in the highest quartile of dietary IL
had higher intakes of fiber and lower intakes of fat com-
pared to those in the lowest one; in addition to influen-
cing on the calculated dietary IL score, these nutritional
factors can also have a modifying effect on the associ-
ation between the insulin indices and development of
CVD, independently in the form of a healthy diet. Third,
the insulin index values of food items were derived from
reports conducted on the young lean students whose in-
sulin responses can be relatively different from our adult
and elderly participants [8]. Fourth, the incidence rate of
CVD events was significantly higher in the participants
in the fourth quartile of the IL than those in the lowest
quartile (Q4: 59.0 per 10,000 person-years vs. Q1: 41.1
per 10,000 person-years). This significant difference in
the incidence rate of CVD was also observed in the par-
ticipants based on quartiles of GL (Q4: 69.9 per 10,000
person-years vs. Q1: 49.8 per 10,000 person-years).
However, the low power of the study due to the low
sample size and a limited number of CVD cases in each
quartile of IL led to provide non-significant findings in
our study.
A subgroup analysis in this prospective cohort study
on 243 individuals with dysglycemia revealed that the
dietary pattern with high GL and IL can be related
strongly with increased risk of CVD in high-risk partici-
pants. It has been previously reported that most individ-
uals with dysglycemia have both hyperinsulinemia and
insulin resistance and they are prone to CVD outcomes,
such as coronary heart disease and stroke. Therefore, a
dietary pattern with high GL and IL is likely to be asso-
ciated with an increased risk of insulin resistance,
atherogenesis, and subsequently an increased risk of
CVD [38].
Some reports have suggested supporting mechanisms
and pathways, which can explain a beneficial association
between these indices and the risk of CVD incidence.
The beneficial effect of low GL or GI diets on reducing
cardio-metabolic risk factors, including total cholesterol,
low-density lipoprotein-cholesterol, triglycerides, BMI,
and plasminogen activator inhibitor-1 concentrations
have also been reported previously [39, 40]. Also, the
high dietary GI is associated with higher plasma levels of
tumor necrosis factor-a, interleukin 6, and C-reactive
protein [40, 41]. Furthermore, blood glucose concentra-
tion increases, and stimulates insulin release after con-
suming high-GI foods with the same amount of
carbohydrate,. The chronically increased insulin demand
may eventually lead to the destruction of pancreatic β
cells, and consequently resulting in impaired glucose tol-
erance. Also, high-GI diets can directly increase insulin
resistance through their effect on glycemia and free fatty
acids [42]. Some reports have suggested the potential
mechanisms through which dietary II and IL might in-
fluence the CVD risk factors. High II of diet may in-
crease the risk of obesity by stimulating more insulin
secretion, which can reduce fat oxidation and increase
carbohydrate oxidation, causing an increase in fat stor-
age [43]. Also, high dietary IL and II can be linked to β-
cell dysfunction and increased insulin resistance through
influencing insulin secretion [13].
The current study is subject to some limitations; the
Iranian food composition table was incomplete and the
USDA nutrient databank was mostly used for the dietary
analyses. Also, it will be difficult to generalize our find-
ings to other societies because of the differences in the
food culture and food intake values of the study partici-
pants. Furthermore, despite adjusting for a wide variety
of variables in our analysis, the confounding effect of
some unknown or unmeasured residual confounding
may have occurred. Despite these limitations, to date,
this is the first study that assessed the association of
dietary II and IL with the incidence of CVD conducted
in the Middle East and North Africa region. The pro-
spective setting, long duration of follow-up, and the use
of valid and reliable food-frequency and physical activity
questionnaires were other strengths of the current study.
Conclusions
In conclusion, the findings of the current population-
based cohort study revealed that a dietary pattern with
higher GL is associated with the increased risk of CVD;
however, no association was found between the dietary
GI, II, and IL and the risk of CVD. Further observational
studies with long-term follow up are required to address
the role of a diet with high II and IL in the development
of CVD outcomes and its potential mechanisms.
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